SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-21-005876
Filing Date
2021-09-08
Accepted
2021-09-08 16:12:22
Documents
2
Period of Report
2021-09-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1746
2 POA - JEAN BENNETT poa-bennett.txt EX-24 3340
  Complete submission text file 0001562180-21-005876.txt   6618
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Issuer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O REGENXBIO INC. 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
Bennett Jean (Reporting) CIK: 0001872219 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37553 | Film No.: 211242268